Installer Kaleta App
Accès rapide & mode hors-ligne
Cipla is a leading global pharmaceutical company headquartered in Mumbai, India. Established in 1935, the company has been at the forefront of providing affordable and innovative medicines. Cipla’s commitment to healthcare is evident through its extensive portfolio of over 1,500 products across various therapeutic categories. The company operates in more than 80 countries, ensuring access to high-quality medications worldwide. With a strong focus on research and development, Cipla continues to pioneer new treatments and expand its reach, particularly in emerging markets.
In Africa, Cipla has established a significant presence, contributing to the continent’s healthcare landscape by offering a wide range of pharmaceutical products, including antiretrovirals, respiratory, and oncology medications. The company’s efforts in Africa are supported by strategic partnerships and collaborations with local governments and healthcare organizations. Cipla’s dedication to improving healthcare access aligns with its mission of ‘Caring for Life,’ as it strives to make a meaningful impact on the lives of millions across the continent.
Cipla operates in multiple African countries, including South Africa, Uganda, Kenya, and Nigeria, among others.
Cipla is involved in numerous programs aimed at increasing access to essential medicines, particularly in the areas of HIV/AIDS, respiratory diseases, and oncology. The company also invests in local manufacturing and capacity-building initiatives to enhance healthcare infrastructure in Africa.
Cipla has significantly impacted public health in Africa by providing affordable medications to millions of patients. Its efforts in the fight against HIV/AIDS have been particularly noteworthy, with Cipla being a major supplier of antiretroviral drugs across the continent. The company’s commitment to innovation and quality continues to drive its success and influence in the global pharmaceutical industry.
